Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.

Colgate-Palmolive's adjusted EPS reached $0.91, exceeding analyst expectations of $0.89. Revenue fell slightly short at $4.944 billion compared to the $4.98 billion estimate. The company ...

Consumer goods manufacturer Colgate-Palmolive (NYSE:CL) reported mixed fourth-quarter and full-year 2024 earnings on Friday, Jan. 31. Adjusted earnings per share (EPS) for Q4 rose to $0.91 ...

Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone.

Colgate-Palmolive (NYSE:CL), a global leader in consumer products, has demonstrated resilience in the face of economic headwinds and market volatility. The company's strong brand portfolio and ...

Toothpaste and toothbrush giant Colgate-Palmolive hit a full-year revenue milestone in 2024 Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting ...

In a report released today, Mark Astrachan from Stifel Nicolaus maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a ...

Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...

Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive. The Motley Fool has a disclosure policy.

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.